Thomas Prukop

874 total citations
11 papers, 525 citations indexed

About

Thomas Prukop is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Thomas Prukop has authored 11 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cellular and Molecular Neuroscience, 4 papers in Neurology and 3 papers in Molecular Biology. Recurrent topics in Thomas Prukop's work include Hereditary Neurological Disorders (5 papers), Peripheral Neuropathies and Disorders (3 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Thomas Prukop is often cited by papers focused on Hereditary Neurological Disorders (5 papers), Peripheral Neuropathies and Disorders (3 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Thomas Prukop collaborates with scholars based in Germany and Italy. Thomas Prukop's co-authors include Michael W. Sereda, Klaus‐Armin Nave, Johannes Matthaei, Mladen V. Tzvetkov, Jürgen Brockmöller, Gerd Meyer zu Hörste, Frank Faltraco, David Liebetanz, Wiebke Möbius and Ruth M. Stassart and has published in prestigious journals such as Nature Medicine, PLoS ONE and Annals of Neurology.

In The Last Decade

Thomas Prukop

11 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Prukop Germany	11	293	146	133	130	84	11	525
Johann Penzien Germany	14	106 0.4×	38 0.3×	268 2.0×	143 1.1×	69 0.8×	17	627
Sac-Pham Tang United Kingdom	6	80 0.3×	122 0.8×	132 1.0×	28 0.2×	41 0.5×	9	364
Lucius A. Passani United States	6	243 0.8×	50 0.3×	267 2.0×	43 0.3×	7 0.1×	6	427
Arpna Srivastava India	12	107 0.4×	56 0.4×	261 2.0×	10 0.1×	36 0.4×	26	510
Ruth M. Lightfoot United States	9	131 0.4×	104 0.7×	163 1.2×	38 0.3×	41 0.5×	12	406
Marcela Sjöberg Chile	13	73 0.2×	47 0.3×	484 3.6×	24 0.2×	35 0.4×	18	677
Jia Zou China	12	81 0.3×	49 0.3×	168 1.3×	15 0.1×	16 0.2×	19	412
Nsikan Akpan United States	9	90 0.3×	24 0.2×	252 1.9×	30 0.2×	16 0.2×	10	416
Meenu Madan United States	12	109 0.4×	22 0.2×	305 2.3×	35 0.3×	42 0.5×	16	496
B. Mitrovic United States	4	54 0.2×	26 0.2×	117 0.9×	33 0.3×	17 0.2×	4	431

Countries citing papers authored by Thomas Prukop

Since Specialization

Citations

This map shows the geographic impact of Thomas Prukop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Prukop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Prukop more than expected).

Fields of papers citing papers by Thomas Prukop

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Prukop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Prukop. The network helps show where Thomas Prukop may publish in the future.

Co-authorship network of co-authors of Thomas Prukop

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Prukop. A scholar is included among the top collaborators of Thomas Prukop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Prukop. Thomas Prukop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Rafehi, Muhammad, Frank Faltraco, Johannes Matthaei, et al.. (2019). Highly Variable Pharmacokinetics of Tyramine in Humans and Polymorphisms in OCT1, CYP2D6, and MAO-A. Frontiers in Pharmacology. 10. 1297–1297. 21 indexed citations

Prukop, Thomas, Jan Stenzel, Theresa Kungl, et al.. (2019). Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A). PLoS ONE. 14(1). e0209752–e0209752. 28 indexed citations

Matthaei, Johannes, et al.. (2018). OCT1 Deficiency Affects Hepatocellular Concentrations and Pharmacokinetics of Cycloguanil, the Active Metabolite of the Antimalarial Drug Proguanil. Clinical Pharmacology & Therapeutics. 105(1). 190–200. 28 indexed citations

Tzvetkov, Mladen V., Johannes Matthaei, Sherin Pojar, et al.. (2017). Increased Systemic Exposure and Stronger Cardiovascular and Metabolic Adverse Reactions to Fenoterol in Individuals with Heritable OCT1 Deficiency. Clinical Pharmacology & Therapeutics. 103(5). 868–878. 56 indexed citations

Sociali, Giovanna, Thomas Prukop, Ilaria Cervellini, et al.. (2016). Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy. Neurobiology of Disease. 95. 145–157. 25 indexed citations

Matthaei, Johannes, Frank Faltraco, Joao N.S. Pereira, et al.. (2015). OCT1 mediates hepatic uptake of sumatriptan and loss‐of‐functionOCT1polymorphisms affect sumatriptan pharmacokinetics. Clinical Pharmacology & Therapeutics. 99(6). 633–641. 81 indexed citations

Prukop, Thomas, Philipp Albrecht, Ruth M. Stassart, et al.. (2015). Curcumin therapy in a Plp1 transgenic mouse model of Pelizaeus‐Merzbacher disease. Annals of Clinical and Translational Neurology. 2(8). 787–796. 18 indexed citations

Fledrich, Robert, Ruth M. Stassart, Thomas Prukop, et al.. (2014). Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A. Nature Medicine. 20(9). 1055–1061. 134 indexed citations

Prukop, Thomas, Sven P. Wichert, Robert Fledrich, et al.. (2014). Progesterone Antagonist Therapy in a Pelizaeus-Merzbacher Mouse Model. The American Journal of Human Genetics. 94(4). 533–546. 22 indexed citations

10.

Hörste, Gerd Meyer zu, Thomas Prukop, David Liebetanz, et al.. (2007). Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy. Annals of Neurology. 61(1). 61–72. 97 indexed citations

11.

Hörste, Gerd Meyer zu, Thomas Prukop, Klaus‐Armin Nave, & Michael W. Sereda. (2006). Myelin Disorders: Causes and Perspectives of Charcot-Marie-Tooth Neuropathy. Journal of Molecular Neuroscience. 28(1). 77–88. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact